Multiple Sclerosis Journal - Experimental, Translational and Clinical Impact Factor in Neuroscience Journals
Multiple Sclerosis Journal - Experimental, Translational and Clinical in Neuroscience Journals
Journal Country: United Kingdom
Journal Q tier: Q2
Publishing Firm: SAGE Publications Inc.
History: 2015-2022
Journal Homepage: Not Available
Journal ISSN: 20552173
Research Categories
Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3)
About Multiple Sclerosis Journal - Experimental, Translational and Clinical
Multiple Sclerosis Journal - Experimental, Translational and Clinical is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q2); Cellular and Molecular Neuroscience (Q3). It is published by SAGE Publications Inc.. The overall rank of Multiple Sclerosis Journal - Experimental, Translational and Clinical is 6949.According to SCImago Journal Rank (SJR), this journal is ranked 0.714. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 25. The best quartile for this journal is Q2.The ISSN of Multiple Sclerosis Journal - Experimental, Translational and Clinical journal is 20552173.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Multiple Sclerosis Journal - Experimental, Translational and Clinical is cited by a total of 477 articles during the last 3 years (Preceding 2022).
Log in to add a review. Log in
No reviews yet. Be the first to review this journal.